We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Photoactive Dye Could Prevent Surgical Infection

By HospiMedica International staff writers
Posted on 02 Jun 2015
A novel antimicrobial dye activated by light could help prevent bacteria from growing on bone fragments used in reconstructive surgery, according to a new study. More...


Researchers at Thomas Jefferson University (Philadelphia, PA, USA) treated bone chips with 5, 10, 15, 20-tetrakis-(4-aminophenyl)-porphyrin) (TAPP), a green dye that is stable while in the dark. But when illuminated, TAPP becomes active, producing reactive oxygen species (ROS) that rapidly kill bacteria. TAPP adsorption to a bone allograft and long-term stability were determined spectrophotometrically, and antimicrobial activity was measured while activated with light or in the dark during incubation with S. aureus or after allograft biofilm formation.

The researchers found that the dye porphyrins strongly adhered strongly to bone allograft, without any trace of leaching out into surrounding fluid,and that the bacteria were unable to sequester TAPP from the TAPP-allograft. When illuminated, the TAPP-allograft became resistant to bacterial adherence, and was also able to disrupt existing biofilms. The strong adherence also suggests, according to the researchers, that it could be safe and non-toxic to normal tissue. The study was published online on April 17, 2015, in Clinical Orthopaedics and Related Research.

“Bacteria really love to hide and grow in the nooks and crannies of porous bone and bone fragments—it’s one of the most perfect surfaces for bacterial growth,” said lead author Noreen Hickok, PhD, an associate professor of orthopedic surgery. “We used a class of chemicals called porphyrins that are tolerated very well by the body in the dark and appear to have excellent antimicrobial properties in the presence of light. These properties allow sterilization during surgical procedures, which occur in bright light.”

“The TAPP dye could be added to the currently used protocols for sterilizing the bone prior to use in surgery,” added Dr. Hickok. “Sterilization could then occur in two steps—one which was achieved with a targeted illumination, and the other would be the continuation of the activation in the bright lights of the surgical suite so that the sterilizing effects of the ROS release could continue well into surgery and implantation.”

Allograft bone is derived from humans. It is typically sourced from a bone bank, originating either from cadavers or from the femoral head of living human bone donors who are undergoing elective total hip arthroplasty. There are three types of bone allograft available - fresh or fresh-frozen bone; freeze-dried bone allograft (FDBA); and demineralized freeze-dried bone allograft (DFDBA).

Related Links:

Thomas Jefferson University



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.